Corpus Intelligence IC Memo — LAKE GRANBURY MEDICAL CENTER 2026-04-27 03:29 UTC
IC Memo — LAKE GRANBURY MEDICAL CENTER
Investment Committee Memorandum | TX | 53 beds | Grade B | EBITDA uplift $13.4M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 450596

LAKE GRANBURY MEDICAL CENTER

LOCATIONHOOD, TX·BEDS53·AS OFApril 27, 2026
B
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

LAKE GRANBURY MEDICAL CENTER is a 53-bed suburban community hospital in HOOD, TX with $181.6M in net patient revenue and a 38.5% operating margin. The hospital serves a payer mix of 30.2% Medicare, 5.2% Medicaid, and 64.6% commercial.

Thesis: Turnaround. Our ML models identify $13.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 38.5% to 45.8% (+736bps).

Net Revenue HCRIS$181.6M
Current EBITDA COMPUTED$69.8M
Operating Margin COMPUTED38.5%
Occupancy HCRIS70.0%
Revenue / Bed COMPUTED$3.4M
Net-to-Gross HCRIS15.1%
Distress Probability ML39.0%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
226
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 38.5% places it above the state median. Among 226 size-comparable peers (26-106 beds), the median margin is 0.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (26-106), prioritizing same-state peers. 226 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LAKE GRANBURY MEDICAL CENTER (Target)TX53$181.6M38.5%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
PRESBYTERIAN HOSP FLOWER MOUNDTX99$215.0M28.3%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
BAYLOR INSTITUTE FOR REHABILITTX92$163.9M-3.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $13.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.8M+210bp18mo
Cost to Collect4.5%2.5%$3.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.2M+122bp9mo
Clean Claim Rate88.0%96.0%$116K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.8M
Cost to Collect
$3.6M
Denial Rate Reduction
$3.6M
A/R Days Reduction
$2.2M
Clean Claim Rate
$116K
Total EBITDA Uplift$13.4M
Current EBITDA$69.8M
+ RCM Uplift+$13.4M
Pro Forma EBITDA$83.2M
Current Margin38.5%
Pro Forma Margin45.8%
WC Released (1x)$7.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$107.4M$594.3M5.53x40.8%
Base (11x exit)10.0x11.0x$107.4M$688.6M6.41x45.0%
Bull Case9.0x11.0x$96.7M$767.6M7.94x51.3%
Bull (12x exit)9.0x12.0x$96.7M$866.0M8.96x55.0%
Bear Case11.0x10.0x$118.2M$492.6M4.17x33.0%
Bear (11x exit)11.0x11.0x$118.2M$580.2M4.91x37.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 226 hospitals with 26-106 beds
  • Same-state prioritization (n=227)
  • Comp margins: P25=-14.4% / P50=0.1% / P75=11.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.